Date published: 2026-5-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

5430413K10Rik Activators

5430413K10Rik Activators encompass a diverse array of chemical compounds that indirectly foster the functional activity of 5430413K10Rik via various signaling cascades. The activation of adenylyl cyclase by Forskolinleads to an increase in cAMP, which in turn stimulates protein kinase A (PKA). PKA can phosphorylate and thus enhance the activity of 5430413K10Rik, assuming it is a kinase-dependent protein. Similarly, the cAMP analog 8-Bromo-cAMP could directly stimulate PKA, potentially leading to the phosphorylation and consequent activation of 5430413K10Rik. Ionomycin and A23187, both of which elevate intracellular calcium levels, can activate calcium-dependent kinases such as CaMK, which may phosphorylate and enhance the activity of 5430413K10Rik. PMA, an activator of protein kinase C (PKC), may also enhance 5430413K10Rik activity through PKC-mediated phosphorylation, assuming 5430413K10Rik is involved in a PKC-dependent signaling pathway.

The bioactive lipid sphingosine-1-phosphate (S1P) activates S1P receptors, initiating signaling that engages the PI3K/Akt pathway, which could lead to the activation of 5430413K10Rik through post-translational modifications. EGCG, known for kinase inhibition, could activate pathways that are under negative control by these kinases, potentially enhancing 5430413K10Rik activity if it lies downstream. The PI3K inhibitor LY294002 may induce the activity of compensatory pathways that enhance 5430413K10Rik activity, while SB203580 and U0126, by inhibiting p38 MAPK and MEK1/2 respectively, might shift signaling towards pathways that activate 5430413K10Rik. Anisomycin's activation of the JNK pathway could similarly enhance the function of 5430413K10Rik, provided it is associated with stress-activated signaling. Lastly, the calcium chelator BAPTA-AM can indirectly influence calcium-dependent signaling processes, potentially leading to the enhancement of 5430413K10Rik through secondary calcium-dependent phosphorylation events. Each activator, by affecting distinct signaling pathways, contributes to the heightened functional activity of 5430413K10Rik without the need for upregulating its expression or direct activation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

8-Bromoadenosine 3′,5′-cyclic monophosphate

23583-48-4sc-217493B
sc-217493
sc-217493A
sc-217493C
sc-217493D
25 mg
50 mg
100 mg
250 mg
500 mg
$108.00
$169.00
$295.00
$561.00
$835.00
2
(1)

As a cell-permeable cAMP analog, 8-Bromo-cAMP can mimic the action of endogenous cAMP and activate PKA. PKA activation can subsequently phosphorylate 5430413K10Rik, potentially increasing its functional activity.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin acts as a calcium ionophore, raising intracellular calcium levels. Elevated calcium can activate calcium-dependent protein kinases (such as CaMK), which might enhance the activity of 5430413K10Rik through phosphorylation.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA is a potent activator of protein kinase C (PKC). Activated PKC could phosphorylate and enhance the activity of 5430413K10Rik if it is part of a PKC-dependent signaling pathway.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$165.00
$322.00
$570.00
$907.00
$1727.00
7
(1)

Sphingosine-1-phosphate (S1P) is a bioactive lipid that activates S1P receptors, leading to downstream signaling via PI3K/Akt pathway. Activation of this pathway may enhance the activity of 5430413K10Rik by post-translational modifications or allosteric changes.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG is known to have kinase inhibitory activity which can lead to the activation of pathways that are negatively regulated by these kinases. If 5430413K10Rik is regulated by such a pathway, EGCG may enhance its activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor, which could lead to the activation of compensatory pathways that may enhance the activity of 5430413K10Rik, if it is involved in such pathways.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a specific inhibitor of p38 MAPK. Inhibition of p38 MAPK can shift signaling towards alternative pathways, potentially enhancing the activity of 5430413K10Rik if it operates within these alternative pathways.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$99.00
$259.00
36
(2)

Anisomycin is a potent activator of the stress-activated protein kinases/JNK pathway. Activation of this pathway could enhance the activity of 5430413K10Rik if it is a substrate or modulator of this pathway.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

A23187 is another calcium ionophore raising intracellular calcium levels, potentially activating calcium-dependent enzymes that may enhance the activity of 5430413K10Rik.

BAPTA/AM

126150-97-8sc-202488
sc-202488A
25 mg
100 mg
$138.00
$458.00
61
(2)

BAPTA-AM is a cell-permeable calcium chelator that can indirectly alter calcium signaling. Altered calcium signaling might lead to the activation of 5430413K10Rik through changes in calcium-dependent phosphorylation events.